Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Financial Information with Respect to Company's Reportable Segments

Presented below is the financial information with respect to the Company’s reportable segments:

	Three Months Ended September 30,
(in thousands)	2020			2019			Change
Revenue:
Therapeutics	$	7,048		$	4,719		$	2,329
Food		315			146			169
Total segment revenue		7,363			4,865			2,498
Segment operational cash expenditures:
Therapeutics		17,612			18,371			(759	)
Food		1,467			1,942			(475	)
Total segment operational cash expenditures		19,079			20,313			(1,234	)
Segment operating loss:
Therapeutics		(10,564	)		(13,652	)		3,088
Food		(1,152	)		(1,796	)		644
Total segment operating loss		(11,716	)		(15,448	)		3,732
Adjustments to reconcile segment operating loss to consolidated    loss from operations:
Corporate general and administrative cash expenditures		(6,308	)		(6,581	)		273
Interest income received		(28	)		(1,236	)		1,208
Depreciation and amortization		(2,229	)		(1,401	)		(828	)
Amortization of right-of-use asset		(270	)		—			(270	)
Share-based compensation		(3,709	)		(2,491	)		(1,218	)
Loss on disposal of assets		—			—			—
Changes in prepaid expenses, accounts payable and accrued expenses		(1,784	)		5,179			(6,963	)
Total consolidated loss from operations	$	(26,044	)	$	(21,978	)	$	(4,066	)

	Nine Months Ended September 30,
(in thousands)	2020			2019			Change
Revenue:
Therapeutics	$	13,541		$	14,357		$	(816	)
Food		1,898			1,359			539
Total segment revenue		15,439			15,716			(277	)
Segment operational cash expenditures:
Therapeutics	$	55,986		$	53,024		$	2,962
Food		5,873			6,126			(253	)
Total segment operational cash expenditures		61,859			59,150			2,709
Segment operating loss:
Therapeutics	$	(42,445	)	$	(38,667	)	$	(3,778	)
Food		(3,975	)		(4,767	)		792
Total segment operating loss		(46,420	)		(43,434	)		(2,986	)
Adjustments to reconcile segment operating loss to consolidated    loss from operations:
Corporate general and administrative cash expenditures	$	(22,925	)	$	(24,726	)	$	1,801
Interest income received		(795	)		(3,322	)		2,527
Depreciation and amortization		(6,587	)		(3,508	)		(3,079	)
Amortization of right-of-use asset		(755	)		—			(755	)
Share-based compensation		(9,932	)		(6,319	)		(3,613	)
Loss on disposal of assets		—			(22	)		22
Changes in prepaid expenses, accounts payable and accrued expenses		1,066			15,988			(14,922	)
Total consolidated loss from operations	$	(86,348	)	$	(65,343	)	$	(21,005	)